Medico Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
18.47
-0.39 (-2.07%)
BSENSE

Nov 20

BSE+NSE Vol: 2.77 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Makers Labs.
Kimia Bioscien.
Medico Remedies
Quest Laborato.
Syschem (India)
Sotac Pharma.
Natural Capsules
Auro Labs.
Parnax Lab
Guj. Inject(Ker)
Himalaya Nutrave
Why is Medico Remedies Ltd ?
1
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 01-Sep-26 and has generated -52.53% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
2
Below par performance in long term as well as near term
  • Along with generating -63.75% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Medico Remedies for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Medico Remedies
-63.75%
-1.09
58.75%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
17.46%
EBIT Growth (5y)
31.61%
EBIT to Interest (avg)
8.05
Debt to EBITDA (avg)
1.05
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
2.28
Tax Ratio
27.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.60%
ROCE (avg)
15.43%
ROE (avg)
17.16%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
11
Industry P/E
40
Price to Book Value
1.91
EV to EBIT
12.09
EV to EBITDA
10.03
EV to Capital Employed
1.68
EV to Sales
0.70
PEG Ratio
0.56
Dividend Yield
NA
ROCE (Latest)
13.89%
ROE (Latest)
16.97%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
PAT(9M)

At Rs 10.76 cr has Grown at 23.25%

NET SALES(Q)

Highest at Rs 73.97 cr

-3What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 2.15 times

NON-OPERATING INCOME(Q)

is 40.06 % of Profit Before Tax (PBT

EPS(Q)

Lowest at Rs 0.29

Loading Valuation Snapshot...
Here's what is working for Medico Remedies
Net Sales - Quarterly
At Rs 73.97 cr has Grown at 40.52%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Nine Monthly
At Rs 10.76 cr has Grown at 23.25%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 73.97 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Medico Remedies
Non Operating Income - Quarterly
is 40.06 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.29
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Debtors Turnover Ratio- Half Yearly
Lowest at 2.15 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio